参考文献/References:
[1] LAMB J N,HOLTON C,O'CONNOR P,et al.Avascular necrosis of the hip[J].BMJ,2019,365:l2178.
[2] KRENN V,MÜLLER S,KRENN V T,et al.Pathophysiology of aseptic femoral head necrosis:Pathogenesis and histo-pathological differential diagnosis[J].Orthopade,2018,47(9):710-716.
[3] 中国医师协会骨科医师分会骨循环与骨坏死专业委员会,中华医学会骨科分会骨显微修复学组,国际骨循环学会中国区.中国成人股骨头坏死临床诊疗指南(2020)[J].中华骨科杂志,2020,40(20):1365-1376.
[4] 魏秋实,杨帆,陈哓俊,等.激素性与酒精性股骨头坏死患者骨标本坏死区域病理与显微结构特点分析[J].中国修复重建外科杂志,2018,32(7):866-872.
[5] 中华医学会骨科学分会关节外科学组.股骨头坏死临床诊疗规范[J].中国矫形外科杂志,2016,24(1):49-54.
[6] GARDENIERS J W M.A new international classification of osteonecrosis of the ARCO committee on terminology and classification[J].ARCO News Letter,1992,4:41-46.
[7] 何伟.精确诊断前提下股骨头坏死非手术治疗实践[J].临床外科杂志,2017,25(8):580-582.
[8] 刘芳,黄海,杨槐,等.骨质疏松性股骨颈骨折扫描电镜观察[J].广东医学,2010,31(7):843-845.
[9] NANGO N,KUBOTA S,HASEGAWA T,et al.Osteocyte-directed bone demineralization along canaliculi[J].Bone,2016,84:279-288.
[10] SASAKI M,KUROSHIMA S,AOKI Y,et al.Ultrastructural alterations of osteocyte morphology via loaded implants in rabbit tibiae[J].J Biomech,2015,48(15):4130-4141.
[11] KUSUMBE A P,RAMASAMY S K,ADAMS R H.Coupling of angiogenesis and osteogenesis by a specific vessel subtype in bone[J].Nature,2014,507(7492):323-328.
[12] CHIM S M,TICKNER J,CHOW S T,et al.Angiogenic factors in bone local environment[J].Cytokine Growth Factor Rev,2013,24(3):297-310.
[13] GAO S Y,LIN R B,HUANG S H,et al.PDGF-BB exhibited therapeutic effects on rat model of bisphosphonate-related osteonecrosis of the jaw by enhancing angiogenesis and osteogenesis[J].Bone,2021,144:115117.
[14] RAHMAN M M,MATSUOKA K,TAKESHITA S,et al.Secretion of PDGF isoforms during osteoclastogenesis and its modulation by anti-osteoclast drugs[J].Biochem Biophys Res Commun,2015,462(2):159-164.
[15] XIE H,CUI Z,WANG L,et al.PDGF-BB secreted by pre-osteoclasts induces angiogenesis during coupling with osteogenesis[J].Nat Med,2014,20(11):1270-1278.
[16] 沈莹姗,何晓铭,赵雄,等.关于“血瘀证是股骨头坏死主要证候”的调查研究[J].中医正骨,2022,34(4):25-29.
[17] 徐传毅.袁浩教授从血瘀证论治激素性股骨头坏死经验[J].中医药学刊,2003,21(2):194-195.
[18] 何伟,徐传毅,李雄,等.酒精性股骨头坏死血液流变学改变及意义[J].中医正骨,2001,13(10):8-9.
[19] 中华中医药学会.股骨头坏死中医辨证标准(2019年版)[J].中医正骨,2019,31(6):1-2.
[20] 吴以岭,贾振华,常丽萍,等.脉络学说营卫理论指导血管病变防治研究[J].中国实验方剂学杂志,2019,25(1):1-10.
[21] 吴以岭.“脉络-血管系统”相关性探讨[J].中医杂志,2007,48(1):5-8.
[22] 吴相春,来静,吴以岭,等.络气郁滞证候对血管内皮的作用及机制研究[J].中国中医基础医学杂志,2009,15(11):823-824.
[23] 贾振华,高怀林,谷春华,等.基于3469 例血管病变患者证候分布规律的脉络病变共性病机探讨[J].中医杂志,2009,50(10):920-924.
相似文献/References:
[1]陈雷雷,张颖.何伟教授采用中医药疗法治疗股骨头坏死的经验[J].中医正骨,2015,27(10):74.
[2]徐西林,赵永兰,张晓峰,等.活骨注射液髋关节腔灌注对兔股骨头坏死模型
血管内皮生长因子表达的动态影响[J].中医正骨,2015,27(08):1.
XU Xilin,ZHAO Yonglan,ZHANG Xiaofeng,et al.Dynamic effect of intra-articular hip injection of Huogu injection on the expression of vascular endothelial growth factor in rabbit models with femur head necrosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(05):1.
[3]周勇,任菲菲,丰凡翔,等.血管内皮生长因子和骨形态发生蛋白2
在非创伤性股骨头坏死不同区域的表达[J].中医正骨,2015,27(08):7.
ZHOU Yong,REN Feifei,FENG Fanxiang,et al.Expressions of vascular endothelial growth factor and bone morphogenetic protein 2 in different zones of femoral head with non-traumatic osteonecrosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(05):7.
[4]鲍荣华,王国平,夏晓斌,等.钽棒植入治疗非创伤性股骨头坏死的疗效观察[J].中医正骨,2015,27(02):28.
[5]张兵,马凰富,刘波,等.非创伤性股骨头坏死的舌象定量研究[J].中医正骨,2015,27(04):8.
ZHANG Bing,MA Huangfu,LIU Bo,et al.Quantitative study on tongue manifestation of patients with nontraumatic osteonecrosis of femoral head[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(05):8.
[6]李刚,程春生.股骨头坏死血瘀证症状与平乐郭氏正骨方药药物组成
最大频繁关联模式挖掘[J].中医正骨,2015,27(04):21.
LI Gang,CHENG Chunsheng.Maximal frequent association pattern mining for studying the relationship between BLOOD STASIS syndrome in patients with osteonecrosis of femoral head and drug components of Pingle Guo's orthopedics prescription[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(05):21.
[7]李文龙,梅沉成,杜贵强,等.微创减压植骨多孔钽棒植入治疗
ARCOⅡ期非创伤性缺血性股骨头坏死[J].中医正骨,2016,28(02):43.
[8]张磊,金红婷,童培建.骨健口服液早期干预非创伤性股骨头坏死的临床研究[J].中医正骨,2016,28(03):14.
ZHANG Lei,JIN Hongting,TONG Peijian.Clinical study on Gujian Koufuye(骨健口服液)for early intervention of nontraumatic osteonecrosis of femoral head[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(05):14.
[9]鲍荣华,王国平,夏晓斌,等.直接前入路微创全髋关节置换术治疗晚期股骨头坏死[J].中医正骨,2016,28(03):61.
[10]张超,姚晨,沈计荣.微创髓芯减压打压支撑植骨术结合补肾活血汤口服治疗ARCOⅡ、Ⅲ期股骨头坏死的近期疗效观察[J].中医正骨,2016,28(03):20.
ZHANG Chao,YAO Chen,SHEN Jirong.[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(05):20.
[11]简羿,马茂潇,郭珈宜,等.基于多重免疫组化技术探讨股骨头坏死愈胶囊治疗激素性股骨头坏死的作用机制[J].中医正骨,2024,36(02):23.
JIAN Yi,MA Maoxiao,GUO Jiayi,et al.The mechanism of Gugutou Huaisiyu Jiaonang(股骨头坏死愈胶囊)in treatment of steroid-induced osteonecrosis of femoral head:a multiplex immunohistochemistry technique-based experimental study[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2024,36(05):23.